Skip to content

13F-HR filed by SHANDA ASSET MANAGEMENT HOLDINGS Ltd

SHANDA ASSET MANAGEMENT HOLDINGS Ltd filed this 13F-HR for the quarter ended 2019-06-30, filed 2019-08-14, with 33 holding rows worth $535,814,000.

Accession
0000950103-19-010851
Filed
2019-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2019

A holdings report, 33 entries on the cover page, a total value of $535,814,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $535,814,000 with VALUE read as thousands by filing date, 13F file number 028-16701. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
HAPPEN INC COM NEW52603A208Stock19,562,881$320,831,000thousands by filing date
COMMUNITY HEALTH SYSTEMS INC203668108COMMON STOCK27,484,473$73,384,000thousands by filing date
HERCULES CAPITAL INC427096508COM3,505,755$44,944,000thousands by filing date
Alphabet Inc. Reg. Shares A02079K305COM26,000$28,153,000thousands by filing date
KKR & CO INC48251W104COM1,080,000$27,292,000thousands by filing date
Amazon.com, Inc023135106COM4,000$7,575,000thousands by filing date
Uber Technologies90353T100COM100,000$4,638,000thousands by filing datecall
ALARM COM HLDGS INC COM011642105Stock60,000$3,210,000thousands by filing date
CRISPR THERAPEUTICS AG NAMEN AKTH17182108Stock58,158$2,739,000thousands by filing date
EDITAS MEDICINE INC28106W103COM103,579$2,563,000thousands by filing date
KOHLS CORP500255104COM50,000$2,378,000thousands by filing datecall
UPWORK INC91688F104COM126,160$2,029,000thousands by filing date
ARES CAPITAL CORP04010L103COM103,030$1,848,000thousands by filing date
MEDPACE HLDGS INC COM58506Q109Stock26,882$1,759,000thousands by filing date
IQVIA HLDGS INC COM46266C105Stock9,224$1,484,000thousands by filing date
PTC THERAPEUTICS INC69366J200COM30,332$1,365,000thousands by filing date
SANGAMO THERAPEUTICS INC800677106COM114,410$1,232,000thousands by filing date
CARA THERAPEUTICS INC140755109COM54,984$1,182,000thousands by filing date
LYFT INC55087P104CL A COM14,700$966,000thousands by filing datecall
NEUROCRINE BIOSCIENCES INC64125C109COM10,000$844,000thousands by filing date
INTELLIA THERAPEUTICS INC45826J105COM48,657$797,000thousands by filing date
VANDA PHARMACEUTICALS INC921659108COM44,787$631,000thousands by filing date
AXSOME THERAPEUTICS INC. COM05464T104Stock19,958$514,000thousands by filing date
PRA HEALTH SCIENCES INC69354M108COM4,980$494,000thousands by filing date
ZOGENIX INC.98978L204Common Stock10,000$478,000thousands by filing date
INTRA-CELLULAR THERAPIES INC46116X101COMMON STOCK35,278$458,000thousands by filing date
LABORATORY CORP OF AMERICA50540R409COM NEW2,318$401,000thousands by filing date
ICON PUB LTD CO SHSG4705A100Stock2,499$385,000thousands by filing date
CLOUDERA INC18914U100COM67,400$355,000thousands by filing date
SUPERNUS PHARMACEUTICALS868459108COM10,000$331,000thousands by filing date
CHARLES RIV LABS INTL INC159864107COM2,207$313,000thousands by filing date
ACORDA THERAPEUTICS INC00484M106COM25,957$199,000thousands by filing date
MARINUS PHARMACEUTICALS INC56854Q101COM10,000$42,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950103-19-010851this filing2019-08-14acceptance time not in the bulk data set